Comparison between two drug for reducing cardiovascular response for pneumoperitoneum in laparoscopic surgery
Phase 1
- Registration Number
- CTRI/2021/11/037795
- Lead Sponsor
- Vijayanagar Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient belonging to ASA 1 and 11
Age group 18 to 50 years
Patient undergoing elective laparoscopic surgeries lasting up to 2 hours
Exclusion Criteria
Patient refusal
Known allergy to study drug
History of hypertension, cardiovascular diseases,cerebrovascular diseases, chronic kidney diseases, diabetes mellitus and liver disorders
Patient with serum electrolyte disturbances
Patient with Brady arrhythmias
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Attenuation of haemodynamic responsesTimepoint: just before creating pneumoperitoneum to deflation of pneumoperitoneum
- Secondary Outcome Measures
Name Time Method extubation responsesTimepoint: at the time of extubation;extubation timeTimepoint: from stoppage of inhalation agent to the time extubation